Personnel Information

写真a

Kuboki Ryo


Job title

Graduate Student
To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2016.01
    -
    2016.04
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Advanced Therapeutic Sciences， Hepatobiliary and Pancreatic Surgery， Staff Assistant
  • 2020.10
    　
    　
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Hospital Departments， Department of Sensory, Orthopedic, and Dematologic Medicine， Otorhinolaryngology， Resident
  • 2020.11
    -
    2021.03
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Hospital Departments， Department of Sensory, Orthopedic, and Dematologic Medicine， Otorhinolaryngology， Resident
  • 2024.04
    -
    2024.09
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Maxillofacial and Neck Reconstruction， Department of Head and Neck Surgery， Graduate Student
  • 2024.10
    -
    Now
    Institute of Science Tokyo， -， Graduate Schools， Maxillofacial and Neck Reconstruction， Department of Head and Neck Surgery， Graduate Student
To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Ryutaro Onaga, Tomohiro Enokida, Toshifumi Tomioka, Shingo Sakashita, Masanobu Sato, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Takao Fujisawa, Susumu Okano, Kazuto Matsuura, Makoto Tahara. Intracranial antitumor efficacy of combination treatment with encorafenib plus binimetinib in BRAF V600E-mutated anaplastic thyroid carcinoma. Auris Nasus Larynx. 2025.12; 53 (1): 7-12. ( PubMed, DOI )

  2. Takuma Kishida, Tomohiro Enokida, Ryutaro Onaga, Nobukazu Tanaka, Yuta Hoshi, Takao Fujisawa, Ryo Kuboki, Hideki Tanaka, Susumu Okano, Makoto Tahara. LH-RH agonist monotherapy for androgen receptor-positive recurrent and/or metastatic salivary gland cancer: a retrospective study. Int J Clin Oncol. 2025.08; 30 (8): 1562-1571. ( PubMed, DOI )

  3. Masaaki Suzuki, Mao Kamei, Ryo Kuboki, Yuichi Kawai, Ryosuke Kotani. Prevalence of sleep-disordered breathing in patients who underwent endoscopic nasal sinus surgery: Investigation of nasal obstruction as a risk factor for sleep-disordered breathing. Auris Nasus Larynx. 2025.08; 52 (4): 451-455. ( PubMed, DOI )

  4. Ryutaro Onaga, Tomohiro Enokida, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Masanobu Sato, Naohiro Takeshita, Hideki Tanaka, Takao Fujisawa, Susumu Okano, Hiroshi Nishino, Makoto Ito, Makoto Tahara. Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan. Thyroid. 2025.07; 35 (7): 781-788. ( PubMed, DOI )

  5. Ryutaro Onaga, Tomohiro Enokida, Hirofumi Kuno, Takashi Hiyama, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Naohiro Takeshita, Hideki Tanaka, Hiroshi Nishino, Makoto Ito, Makoto Tahara. Significance of imaging-detected extranodal extension in locally advanced squamous cell carcinoma of the head and neck treated with induction chemotherapy followed by chemoradiotherapy. Oral Oncol. 2025.06; 165 107351. ( PubMed, DOI )

  6. Ryutaro Onaga, Tomohiro Enokida, Shingo Sakashita, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Takao Fujisawa, Susumu Okano, Hiroshi Nishino, Makoto Ito, Genichiro Ishii, Shumpei Ishikawa, Makoto Tahara. Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer. Int J Clin Oncol. 2025.06; 30 (6): 1143-1151. ( PubMed, DOI )

  7. Ryo Kuboki, Fuminori Nomura, Satoshi Yagihashi, Takahiro Asakage. A case of selpercatinib treatment for anaplastic thyroid carcinoma resulting in abscess formation. Int Cancer Conf J. 2024.10; 13 (4): 387-390. ( PubMed, DOI )

  8. Ryutaro Onaga, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Hideki Tanaka, Masanobu Sato, Naohiro Takeshita, Ryo Kuboki, Hiroshi Nishino, Makoto Ito, Makoto Tahara. Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer. Int J Clin Oncol. 2024.07; ( PubMed, DOI )

▼display all

To the head of this page.▲